Gene therapy for sickle cell disease passes key preclinical test
A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.
Денис Савин (@withoutpassions) / X
Sickle cell gene therapy passes key preclinical test - Boston Children's Answers
News & Events - latest news and happenings in the SCD community
Sickle cell gene therapy passes key preclinical test - Boston Children's Answers
Dr.mrs jugesh saluja (@jugeshsaluja) / X
Archives — Page 198 of 873 — Harvard Gazette
Editor's Pick Archives — Page 33 of 225 — Harvard Gazette
Researchers optimize gene editing for SCD and beta thalassemia
Dr.mrs jugesh saluja (@jugeshsaluja) / X